Sjögren's disease & overlap diseases

Real-world damage accrual in Sjögren’s disease: a 5-year multicentre GIRRCS cohort analysis

RMD OpenPublished Retrospective cohort study

Authors' conclusion

Irreversible damage in SD occurs early, often present at diagnosis and affects multiple organ domains.

Study context

Population
Adult patients with SjD from the GIRRCS network with ≥1 year of follow-up
Participants
429 patients
Outcome
Irreversible damage (SSDI) across ocular, oral and systemic domains
Follow-up
5 years
Methodological detailsmulticentre, Cox proportional hazards models, Kaplan-Meier curves, exploratory Least Absolute Shrinkage and Selection Operator (LASSO) and principal component analysis (PCA) analyses
  • Multicentre
  • Cox proportional hazards models
  • Kaplan-Meier curves
  • Exploratory LASSO and PCA analyses

Main finding

As reported in the abstract

Cumulative damage · After 5 years

Cumulative damage

65%

Ocular

34.2%

Oral

21.7%

Systemic

40.8%

Observational data: associations, not effects.

Further findings

Damage at baseline (Sjögren's Syndrome Damage Index (SSDI)≥1)

SSDI≥1
48%
Ocular
25.4%
Systemic
22.5%
Oral
14.3%

Predictors of damage

Higher baseline ESSDAI predicted damage across all domains
Elevated EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) associated with oral damage
Abnormal Schirmer's test strongly predicted ocular damage
Anti-Ro/La antibodies, elevated C reactive protein (CRP) and recurrent oral infections linked to higher domain-specific damage
Glandular, peripheral nervous system and pulmonary ESSDAI domains independently contributed to systemic damage (LASSO)
Patient-reported symptoms and systemic activity are complementary, independent dimensions (PCA)

Original publication

Real-world damage accrual in Sjögren’s disease: a 5-year multicentre GIRRCS cohort analysis. RMD Open. Published 21 May 2026. doi:10.1136/rmdopen-2026-006772

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.